Edition:
United Kingdom

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

31.63USD
24 May 2019
Change (% chg)

$-0.27 (-0.85%)
Prev Close
$31.90
Open
$31.97
Day's High
$32.51
Day's Low
$31.57
Volume
123,051
Avg. Vol
254,780
52-wk High
$39.38
52-wk Low
$10.31

Latest Key Developments (Source: Significant Developments)

Caredx Inc Says Has Filed A Second Lawsuit Against Natera, Inc.
Wednesday, 10 Apr 2019 

April 10 (Reuters) - CareDx Inc ::CAREDX INC - HAS FILED A SECOND LAWSUIT AGAINST NATERA, INC..CAREDX- ALLEGES NATERA'S COMPARISONS OF KIDNEY TRANSPLANT TECH TO CO'S ALLOSURE TECH ARE BASED ON "INAPPROPRIATE CONCLUSIONS".CAREDX INC - CAREDX IS SEEKING ALL AVAILABLE REMEDIES, INCLUDING MONETARY DAMAGES.  Full Article

CareDx Files Patent Infringement Lawsuit Against Natera
Tuesday, 26 Mar 2019 

March 26 (Reuters) - CareDx Inc ::CAREDX FILES PATENT INFRINGEMENT LAWSUIT AGAINST NATERA.CAREDX - SUIT ASSERTS NATERA INFRINGES THROUGH MARKETING & PERFORMANCE OF TEST TO ANALYZE CELL-FREE DNA FROM TRANSPLANT PATIENT TO INFORM REJECTION.  Full Article

Caredx announces full repayment of its outstanding debt
Monday, 26 Nov 2018 

Nov 26 (Reuters) - CareDx Inc ::CAREDX ANNOUNCES FULL REPAYMENT OF ITS OUTSTANDING DEBT.CAREDX INC - PREPAID IN FULL ITS OUTSTANDING DEBT ON NOVEMBER 20, 2018..CAREDX INC - PREPAID DEBT, A $15 MILLION TERM LOAN FROM PERCEPTIVE ADVISORS, WAS OBTAINED ON APRIL 13, 2018.CAREDX INC - IN ADDITION TO $15 MILLION DEBT PREPAYMENT, COMPANY ALSO PAID PERCEPTIVE ADVISORS A PREPAYMENT PREMIUM AND AN EXIT FEE.  Full Article

CareDx Prices Public Offering Of 2 Mln Common Shares At $24.5/Shr
Wednesday, 14 Nov 2018 

Nov 13 (Reuters) - CareDx Inc ::CAREDX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.00 MILLION COMMON SHARES PRICED AT $24.50PER SHARE.  Full Article

CareDx Announces Proposed Public Offering Of Common Stock
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - CareDx Inc ::CAREDX ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.CAREDX INC - INTENDS TO OFFER AND SELL 2 MILLION SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING.  Full Article

Caredx Inc Files For Mixed Shelf Offering Of Up To $200 Million
Friday, 31 Aug 2018 

Aug 31 (Reuters) - CareDx Inc ::CAREDX INC FILES FOR MIXED SHELF OFFERING OF UP TO $200 MILLION.  Full Article

Olerup QTYPE Receives CE Mark Certification
Friday, 13 Apr 2018 

April 13 (Reuters) - Caredx Inc ::OLERUP QTYPE® RECEIVES CE MARK CERTIFICATION.OLERUP QTYPE RECEIVED CE MARK APPROVAL AND IS AVAILABLE ON BOTH ROCHE & APPLIED BIOSYSTEMS PLATFORMS.  Full Article

Caredx Launches Heartcare For Heart Transplant Recipients
Tuesday, 10 Apr 2018 

April 10 (Reuters) - CareDx Inc ::CAREDX LAUNCHES HEARTCARE® FOR HEART TRANSPLANT RECIPIENTS.ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS.  Full Article

CareDx Q4 Non-Gaap Loss Per Share $0.09
Thursday, 22 Mar 2018 

March 22 (Reuters) - CareDx Inc ::CAREDX REPORTS FOURTH QUARTER AND FY2017 FINANCIAL RESULTS.Q4 NON-GAAP LOSS PER SHARE $0.09.Q4 LOSS PER SHARE $1.13.Q4 REVENUE $12.5 MILLION VERSUS I/B/E/S VIEW $12.3 MILLION.SEES FY 2018 REVENUE $61 MILLION TO $63 MILLION.FY2018 REVENUE VIEW $61.5 MILLION -- THOMSON REUTERS I/B/E/S.‍FOR FY 2018, CAREDX EXPECTS REVENUE TO BE IN RANGE OF $61 MILLION TO $63 MILLION, WITH PROFITABILITY EXPECTED DURING SECOND HALF OF YEAR​.  Full Article

Caredx - Entered Binding Commitment With Perceptive Advisors For Term Loan Of Between $15 Mln And $35 Mln
Thursday, 1 Mar 2018 

March 1 (Reuters) - Caredx Inc ::CAREDX - ENTERED BINDING COMMITMENT WITH PERCEPTIVE ADVISORS FOR A TERM LOAN OF BETWEEN $15 MILLION AND $35 MILLION.CAREDX INC - NOTIFIED JGB OF CO'S INTENTION TO PREPAY OUTSTANDING PRINCIPAL BALANCE OF CONVERTIBLE NOTES ISSUED BY CO TO JGB.CAREDX - PERCEPTIVE ADVISORS TERM LOAN TO HAVE INTEREST RATE OF 10.5%, INTEREST-ONLY PERIOD OF 3 YEARS, MATURITY DATE OF APRIL 2023.CAREDX INC - UPON REPAYMENT TO JGB, $9.4 MILLION OF CO'S RESTRICTED CASH WILL BECOME AVAILABLE FOR USE.  Full Article